Literature DB >> 25008937

Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging.

Paul J Wichgers Schreur1, Nadia Oreshkova2, Rob J M Moormann2, Jeroen Kortekaas3.   

Abstract

UNLABELLED: Bunyavirus genomes comprise a small (S), a medium (M), and a large (L) RNA segment of negative polarity. Although the untranslated regions have been shown to comprise signals required for transcription, replication, and encapsidation, the mechanisms that drive the packaging of at least one S, M, and L segment into a single virion to generate infectious virus are largely unknown. One of the most important members of the Bunyaviridae family that causes devastating disease in ruminants and occasionally humans is the Rift Valley fever virus (RVFV). We studied the flexibility of RVFV genome packaging by splitting the glycoprotein precursor gene, encoding the (NSm)GnGc polyprotein, into two individual genes encoding either (NSm)Gn or Gc. Using reverse genetics, six viruses with a segmented glycoprotein precursor gene were rescued, varying from a virus comprising two S-type segments in the absence of an M-type segment to a virus consisting of four segments (RVFV-4s), of which three are M-type. Despite that all virus variants were able to grow in mammalian cell lines, they were unable to spread efficiently in cells of mosquito origin. Moreover, in vivo studies demonstrated that RVFV-4s is unable to cause disseminated infection and disease in mice, even in the presence of the main virulence factor NSs, but induced a protective immune response against a lethal challenge with wild-type virus. In summary, splitting bunyavirus glycoprotein precursor genes provides new opportunities to study bunyavirus genome packaging and offers new methods to develop next-generation live-attenuated bunyavirus vaccines. IMPORTANCE: Rift Valley fever virus (RVFV) causes devastating disease in ruminants and occasionally humans. Virions capable of productive infection comprise at least one copy of the small (S), medium (M), and large (L) RNA genome segments. The M segment encodes a glycoprotein precursor (GPC) protein that is cotranslationally cleaved into Gn and Gc, which are required for virus entry and fusion. We studied the flexibility of RVFV genome packaging and developed experimental live-attenuated vaccines by applying a unique strategy based on the splitting of the GnGc open reading frame. Several RVFV variants, varying from viruses comprising two S-type segments to viruses consisting of four segments (RVFV-4s), of which three are M-type, could be rescued and were shown to induce a rapid protective immune response. Altogether, the segmentation of bunyavirus GPCs provides a new method for studying bunyavirus genome packaging and facilitates the development of novel live-attenuated bunyavirus vaccines.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25008937      PMCID: PMC4178868          DOI: 10.1128/JVI.00961-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus.

Authors:  K Keegan; M S Collett
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Complete nucleotide sequence of the M RNA segment of Rift Valley fever virus.

Authors:  M S Collett; A F Purchio; K Keegan; S Frazier; W Hays; D K Anderson; M D Parker; C Schmaljohn; J Schmidt; J M Dalrymple
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

4.  Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs.

Authors:  M Bouloy; C Janzen; P Vialat; H Khun; J Pavlovic; M Huerre; O Haller
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment.

Authors:  J A Suzich; L T Kakach; M S Collett
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Functional analysis of the noncoding regions of the Uukuniemi virus (Bunyaviridae) RNA segments.

Authors:  Kirsten Flick; Anna Katz; Anna Overby; Heinz Feldmann; Ralf F Pettersson; Ramon Flick
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.

Authors:  B J Barnard
Journal:  J S Afr Vet Assoc       Date:  1979-09       Impact factor: 1.474

9.  Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes.

Authors:  Rebekah C Kading; Mary B Crabtree; Brian H Bird; Stuart T Nichol; Bobbie Rae Erickson; Kalanthe Horiuchi; Brad J Biggerstaff; Barry R Miller
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

10.  The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging.

Authors:  Benjamin Brennan; Stephen R Welch; Richard M Elliott
Journal:  PLoS Pathog       Date:  2014-02-13       Impact factor: 6.823

View more
  23 in total

Review 1.  Molecular aspects of Rift Valley fever virus and the emergence of reassortants.

Authors:  Natasha N Gaudreault; Sabarish V Indran; Velmurugan Balaraman; William C Wilson; Juergen A Richt
Journal:  Virus Genes       Date:  2018-11-13       Impact factor: 2.332

2.  Flexibility of bunyavirus genomes: creation of an orthobunyavirus with an ambisense S segment.

Authors:  Ingeborg van Knippenberg; Richard M Elliott
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 3.  Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.

Authors:  Kaori Terasaki; Breanna R Tercero; Shinji Makino
Journal:  Virus Res       Date:  2015-05-27       Impact factor: 3.303

Review 4.  A Virus Is a Community: Diversity within Negative-Sense RNA Virus Populations.

Authors:  Lavinia J González Aparicio; Carolina B López; Sébastien A Felt
Journal:  Microbiol Mol Biol Rev       Date:  2022-06-23       Impact factor: 13.044

5.  Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.

Authors:  Breanna Tercero; Krishna Narayanan; Kaori Terasaki; Shinji Makino
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

6.  Advancing the Rose Rosette Virus Minireplicon and Encapsidation System by Incorporating GFP, Mutations, and the CMV 2b Silencing Suppressor.

Authors:  Cesar D Urrutia; Gustavo Romay; Brian D Shaw; Jeanmarie Verchot
Journal:  Viruses       Date:  2022-04-17       Impact factor: 5.818

7.  Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.

Authors:  Paul J Wichgers Schreur; Lucien van Keulen; Jet Kant; Nadia Oreshkova; Rob J M Moormann; Jeroen Kortekaas
Journal:  Front Microbiol       Date:  2016-03-07       Impact factor: 5.640

Review 8.  The Strange Lifestyle of Multipartite Viruses.

Authors:  Anne Sicard; Yannis Michalakis; Serafín Gutiérrez; Stéphane Blanc
Journal:  PLoS Pathog       Date:  2016-11-03       Impact factor: 6.823

Review 9.  RNA Encapsidation and Packaging in the Phleboviruses.

Authors:  Katherine E Hornak; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Viruses       Date:  2016-07-15       Impact factor: 5.048

10.  Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments.

Authors:  Paul J Wichgers Schreur; Jeroen Kortekaas
Journal:  PLoS Pathog       Date:  2016-08-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.